Inventor
HIRTH KLAUS PETER
US32 patents
⚠️ This page may combine multiple inventors who share the name “HIRTH KLAUS PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SUGEN INC
19 patentsUS5942385AAug 24, 1999
Method for molecular diagnosis of tumor angiogenesis and metastasis
SUGEN INC145 citations99
US5789427AAug 4, 1998
Methods and compositions for inhibiting cell proliferative disorders
SUGEN INC264 citations98
US5773476AJun 30, 1998
Methods and compositions for inhibiting cell proliferative disorders
SUGEN INC153 citations98
US5763198AJun 9, 1998
Screening assays for compounds
SUGEN INC155 citations98
US5700823ADec 23, 1997
Treatment of platelet derived growth factor related disorders such as cancers
SUGEN INC122 citations98
US6696448B2Feb 24, 2004
3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
SUGEN INC65 citations96
US6610688B2Aug 26, 2003
4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
SUGEN INC74 citations96
US5990141ANov 23, 1999
Treatment of platelet derived growth factor related disorders such as cancers
SUGEN INC189 citations96
US6004967ADec 21, 1999
Psoriasis treatment with quinazoline compounds
SUGEN INC74 citations93
US6147106ANov 14, 2000
Indolinone combinatorial libraries and related products and methods for the treatment of disease
SUGEN INC37 citations92
US5932602AAug 3, 1999
Treatment of platelet derived growth factor related disorders such as cancers
SUGEN INC26 citations92
US6846839B1Jan 25, 2005
Methods for treating diseases and disorders related to unregulated angiogenesis and/or vasculogenesis
SUGEN INC29 citations90
US5958959ASep 28, 1999
Treatment of platelet derived growth factor related disorders such as cancers
SUGEN INC15 citations81
US6908930B2Jun 21, 2005
4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors
SUGEN INC6 citations74
US6906093B2Jun 14, 2005
Indolinone combinatorial libraries and related products and methods for the treatment of disease
SUGEN INC9 citations74
US6316479B1Nov 13, 2001
Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
SUGEN INC10 citations74
US7217737B2May 15, 2007
Method and compositions for inhibiting cell proliferative disorders
SUGEN INC3 citations62
US7202265B2Apr 10, 2007
Indolinone combinatorial libraries and related products and methods for the treatment of disease
SUGEN INC4 citations62
US6649635B2Nov 18, 2003
Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
SUGEN INC1 citations52
PLEXXIKON INC
7 patentsUS9358235B2Jun 7, 2016
Kinase modulation, and indications therefor
PLEXXIKON INC41 citations98
US7863288B2Jan 4, 2011
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC187 citations98
US9730918B2Aug 15, 2017
Kinase modulation, and indications therefor
PLEXXIKON INC25 citations94
US7872018B2Jan 18, 2011
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC48 citations94
US9873700B2Jan 23, 2018
Compounds for kinase modulation, and indications therefor
PLEXXIKON INC20 citations93
US10123998B2Nov 13, 2018
Kinase modulation, and indications therefor
PLEXXIKON INC9 citations84
US10421761B2Sep 24, 2019
Compounds for kinase modulation, and indications therefor
PLEXXIKON INC6 citations82
IBRAHIM PRABHA N
3 patentsUS8143271B2Mar 27, 2012
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N124 citations99
US8470818B2Jun 25, 2013
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N94 citations97
US8415469B2Apr 9, 2013
Compounds and methods for kinase modulation, and indications therefor
IBRAHIM PRABHA N84 citations97